Dominican Republic vs Solomon Islands: Proportion of the target population who received a 3rd dose of
Dominican Republic
87.0%
in 2024
Solomon Islands
88.0%
in 2024
Dominican Republic rank
83rd
Solomon Islands rank
80th
Proportion of the target population who received a 3rd dose of over time
- Dominican Republic
- Solomon Islands
How they compare
Solomon Islands currently reports 88.0% against 87.0% in Dominican Republic, a difference of 1.0%.
The two have swapped places 2 times across 10 shared years of data; in 2015 it was Solomon Islands ahead.
Dominican Republic ranks 83rd and Solomon Islands ranks 80th of 157 countries.
Solomon Islands has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Dominican Republic | Solomon Islands | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 49.8% | 77.6% | 27.8% | Solomon Islands |
| 2020s | 78.2% | 87.4% | 9.2% | Solomon Islands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received a 3rd dose of, Dominican Republic or Solomon Islands?
- Solomon Islands, at 88.0% against 87.0% in Dominican Republic as of 2024.
- What is the difference in proportion of the target population who received a 3rd dose of between Dominican Republic and Solomon Islands?
- 1.0%, with Solomon Islands ahead.
- How many years of comparable data are there for Dominican Republic and Solomon Islands?
- 10 years are reported by both, from 2015 to 2024.
- How do Dominican Republic and Solomon Islands rank globally for proportion of the target population who received a 3rd dose of?
- Dominican Republic ranks 83rd and Solomon Islands ranks 80th of 157 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.